medicinal use of narcotic analgesics in advanced cancer, a group of 500 patients admitted to St Christopher's Hospice was reviewed. To achieve and maintain pain relief many of the patients recesved diamorphine (heroin) regularly every four hours. Almost all the patients received a phenothiazine concurrently; other drugs were prescribed when indicated. It was concluded that: I) Although most patients receive parenteral diamorphine during the last 12 to 24 hours, the majority can be maintained on oral medication until this time. 2) There is no single optimal dose of diamorphine. 3) Psychological dependence does not occur. 4) Physical dependence may develop but does not prevent the downward adjustment of the dose of diamorphine when considered clinically feasible. 5) Tolerance is not a practical problem. 6) The prescription of diamorphine does not, by itself, lead to impairment of mental faculties.
Also discussed are: I) the psychobiological nature of pain; 2) the rational use of analgesics; 3) the need for further research; 4) the importance of the doctor's attitude.
Attention has recently been drawn to a form of iatrogenic drug abuse -the failure to treat patients in severe pain with adequate doses of narcotic analgesics (Marks and Sachar, 1973) , a matter of too little being given too late or not at all. From this and other sources it appears that, because of fears of addiction, the rapid escalation of dose, and the impairment of mental faculties, doctors generally are reluctant to prescribe narcotic analgesics even in patients with advanced cancer. This reluctance is illustrated in the following quotation:
'What about the inoperable cancer patient who may not die for months or a year, and yet who is suffering agonies from chronic pain? This type of patient may fail to get relief from anything but the most potent narcotics. Is a doctor then justified in prescribing such drugs when he knows full well he will be sentencing his patient to a kind of living death?' (Bunyard, I97I (table I) . The median final daily dose for each group was then determined, and, in order to correct for time, divided by the group median duration of treatment. The resulting dose/time coefficients demonstrate clearly that the rate at which the dose increases becomes progressively less the longer the duration of treatment. Further, examination of the individual dose-againsttime graphs prepared for the io8 patients who received diamorphine for at least four weeks indicated that there were four general patterns of diamorphine requirement. These were classified as: step-plateau-step-plateau, plateau, undulating, and crescendo-diminuendo. Their incidence was approximately 40, 40, I5, and 5 per cent respectively.
Forty-six patients were discharged for varying lengths of time (days out and weekends not included) and, of these, 22 were on diamorphine when discharged (table II) . They were all alert and mobile, though one or two of the elderly ones used a walking frame. Messrs, Urban and Schwartzenberg, Munich.)
The main reason for parenteral administration at an early stage was unrelieved nausea and vomiting. Although a range of synthetic narcotics is available in tablet and suppository form, the prescription of morphine or diamorphine is often still equated with injections. This review demonstrates that this is a fallacy as far as diamorphine is concerned, and unpublished data (Twycross) (Fraser, Isbell, and Van Horn, 1957) . However, there is certainly no support for the statement that, due to tolerance, morphine is no longer effective after three months of continuous use (Milton, I972) . In practice, when diamorphine is used as at St Christopher's Hospice regularly, prophylactically and as part of a programme of total care, tolerance, if it occurs, is not a practical problem.
IMPAIRMENT OF MENTAL FACULTIES
As already mentioned, it has been suggested that the administration of a potent narcotic analgesic to a patient with inoperable cancer is like sentencing him 'to a kind of living death' (Bunyard, I97).
Others speak of 'detachment from reality' or imply that patients receiving morphine or diamorphine can do little more than lie 'drugged' in bed. It appears, however, in the present series of patients that an oral daily dose of I50 mg (30 mg X S) is not incompatible with normal activity (table II) . This is borne out by one's own experience of treating several hundred patients with diamorphine which has demonstrated that there is no significant correlation between the dose administered and mobility (Twycross, unpublished observations) . 'Detachment from reality' -if it occurs -and drowsiness would appear to be related more to advanced physical debility than to diamorphine per se.
ADJUVANT MEDICATION
In addition to the concomitant use of a phenothiazine, a quarter of the patients were prescribed either a tricyclic antidepressant or a benzodiazepine tranquillizer. Generally speaking, the latter were used for short periods to help patients at times of particular stress or anxiety while the former were used for longer periods in many of the more long-term survivors. Glucocorticosteroids were prescribed for about half the patients for a variety of reasons (Drug and Therapeutics Bulletin, I974 6 Adjuvant medication is, in practice, the rule rather than the exception. 7 Use oral medication whenever possible: it is easier to administer, enables the patient to be more independent, and facilitates domiciliary care.
8 There is more to analgesia than analgesics. Some pain responds better to other forms of treatment, eg radiotherapy, cytotoxic drugs, nerve blocks, alone or in combination with analgesics.
The value of diversional activity should not be forgotten. It ranges from back rubs to occupational therapy, talking books, access to radio and television, someone to talk to, and dayroom activities. Pain feels worse when it occupies the entire life field. Diversional activity does much more than just 'pass the time'; it also diminishes the pain. Both 'attention' and 'consciousness' are essential to the perception of pain. We can reduce one or other, but the reduction of 'attention' can often be surprisingly effective.
Diamorphine in perspective It is clear that diamorphine cannot be regarded as a panacea for terminal cancer. For instance, more than half the patients who survived 24 weeks after commencing treatment with diamorphine required tricyclic antidepressants. Unless it, or any other analgesic, is used within the context of total patient care, the results will be far from satisfactory.
At St Christopher's, a comparative study of diamorphine and morphine has been completed and, currently, the cocaine in the standard elixir is being evaluated. It is planned to compare diamorphine with other narcotic analgesics and, eventually, to assess the adjunctive use of phenothiazines.
In addition, steps are being taken to elucidate the complex and complicating role of glucocorticosteroids. In case i, for example, it is likely that the patient was hypercalcaemic when admitted: she improved steadily once prednisone was prescribed. Hypercalcaemia is known to precipitate or exacerbate pain in malignant disease and its correction to cause relief (Galasko and Burn, I97I) . It is possible that alteration of the biochemical milieu in other ways may alter the pain threshold and thus a patient's narcotic requirement.
Pain in perspective
Published data suggest that as many as 50% of all terminal cancer patients have no pain at all or negligible discomfort at most. Forty per cent do, however, experience severe pain and the remaining Io% suffer pain of a less intense nature (Turnbull, 1954 ; Aitken-Swan, I959). Further, it is theoretically possible to relieve pain in every case. Success depends on the doctor having an adequate concept of the nature of pain, knowledge concerning the correct use of analgesics and links with specialist colleagues so that assistance can be obtained in 'problem cases'. Equally important is the doctor's attitude to the dying patient:
'As the doctor-patient relationship improved, many doctors found they could reduce the drugs. As the true diagnosis of the patient's pain became clear and the patient was helped to deal with the pain of dying, there was less need for sedatives, tranquillizers, and analgesics. This almost certainly reflected the doctor's own feelings. Once he was
